I have a couple of questions related to the intended use of MedDRA in the OMOP vocabulary and wanted to see if anyone in the OHDSI community had some insight. Looking at the concept relationship and ancestor data in V5, the assumption is that a user referencing a MedDRA term in an analytic query would select condition records in the CDM via the mapping with SNOMED-CT.
Has there been any research done on the coverage of MedDRA term mapping to the source codes indirectly via SNOMED-CT? Many of our users will continue to use MedDRA for drug safety surveillance activities and it would be beneficial to have some factual evidence of the type and quality of coverage (e.g. overall mapping coverage indirectly through SNOMED and the coverage of the most commonly used terms such as listed events or those contained in the IME list). Research seems to validate direct mappings for ICD-9 to MedDRA and ICD-9 to SNOMED without significant loss of data integrity (Reich et al., 2012). Also, has there been any research on the quality of direct mapping of Read to SNOMED or ICD-10 to SNOMED (other than the coverage percentages listed in Appendix C of the OMOP V4 Vocabulary specification)?